FDA Cites Able For Failing To Reject Out-Of-Specification Drugs, Altering Data
Executive Summary
Able Labs routinely failed to reject drugs that did not meet established standards, specifications and quality control criteria, according to FDA inspectional observations included in a "Form 483" report